[1]Lin CL, Liao LY, Liu CJ, et al.Hepatitis B genotypes and precore/basal core promoter mutants in HBeAg-negativer chronic hepatitisB[J].J Gastroenterol, 2002, 37∶283-287.
|
[2] 中华医学会.病毒性肝炎防治方案[J].中华肝脏病杂志, 2000, 8 (6) ∶324-329.
|
[3]Akarca US, Greene S, Lok AS.Detection of precore hepatitis B vi-rus mutants in asmptomatic HBsAg-positive family members[J].Hepatology, 1994, 19∶1366-1370.
|
[4]李琴, 孙桂珍, 魏玉香, 等.前蛋白与病毒DNA和核心抗原对乙型肝炎病毒复制诊断的对比[J].中华肝脏病杂志, 2004, 12∶134-136.
|
[5]Funk ML, Rosenberg DM, Lok AS.World-wide epidem iology ofHBeAg-negative chronic hepatitis B and associated precore and corepromoter variants[J].J Viral Hepat, 2002, 9∶52-61.
|
[1] | Yujie HUANG, Siyi FENG. Application value of two-dimensional shear wave elastography and serological models in the staging of liver fibrosis in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2024, 40(3): 509-515. doi: 10.12449/JCH240312 |
[2] | Zhao Zhao, Qi WenQian, Zhao Ping. Research advances in insulin-like growth factor 1 receptor and its pathway in diagnosis and treatment of primary liver cancer[J]. Journal of Clinical Hepatology, 2017, 33(4): 763-768. doi: 10.3969/j.issn.1001-5256.2017.04.038 |
[3] | Yan XiaoDi, Dong ZhiZhen, Chen Jie, Qiu LiWei, Wu Wei, Yao DengFu. Dynamic expression profile of the insulin-like growth factor-1 receptor during malignant transformation of hepatocytes[J]. Journal of Clinical Hepatology, 2013, 29(3): 217-222. |
[4] | Suo HaiFen, Zhu YaoJu. Effect of sophocarpidine and diammonium glycyrrhizinate injection on hepatic fibrosis and the content of interferon-γ of chronicity type B Hepatitis patients[J]. Journal of Clinical Hepatology, 2010, 26(2): 196-198. |
[6] | Kang HaiYan, Dong JiangLong, Wang JianBin, Li BingShun, Zhang HongXia. Relationship between transforming growth factor β1 and liver fibrosis and liver function in 260 patients with hepatitis B [J]. Journal of Clinical Hepatology, 2009, 25(1): 61-62. |
[7] | Li ChunMing, Huang XiaoYun, Jin YueMing, Gong YuHua, Tan YouWen. Analysis of anti-fibrosis effect of combining lamivudine with captopril in 166 cases with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2009, 25(2): 102-105. |
[8] | Yu HongWei, Meng QingHua, Zhang FenYan, Li Juan, Wang JinHuan, Duan ZhongHui. Research on mechanism of hypoglycemia in Patients with Severe Chronic Hepatitis B.[J]. Journal of Clinical Hepatology, 2008, 24(3): 175-177. |
[9] | Xia Qi, Fu JieHai, Cai WeiMin, Liu RongHua. Diagnostic value of AST/PLT and GGT/PLT for hepatic fibrosis.[J]. Journal of Clinical Hepatology, 2007, 23(5): 364-366. |
[17] | Kong Li, Li BingShun, Ren ZhongXuan, Hu YunLong, Liu JinXing. The study of inhibitory effect of IFN-α therapy for hepatic fibrosis in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2002, 18(6): 356-358. |
[20] | Zhang Min, Zhang LingXia, Xin ShaoJie, Zhao JingMin, Wang SongShan, Wang LinJie. The relationship between transforming growth factor β1 and liver fibrosis[J]. Journal of Clinical Hepatology, 2000, 16(1): 32-33. |